Displaying 5 (all) recruiting clinical trials.
-
A Phase 2 Double-blind Randomized Placebo-controlled Multicenter Study to Evaluate Efficacy Safety and Tolerability of JBT-101 in Systemic Lupus Erythematosus
This research study is being done to test the effect, safety, and tolerability of the experimental drug JBT-101 in subjects with Systemic Lupus Erythematosus (SLE ...Phase
Accepts Healthy Volunteer
-
An Open-Label Study of CK-3773274 for Patients with Symptomatic Hypertrophic Cardiomyopathy (HCM)
HCM is a condition in which the heart muscle becomes abnormally thickened, which can sometimes block the blood flow out of the heart, and the ...Phase
Interventional
Accepts Healthy Volunteer
-
A Phase 2 Open-Label Study to Evaluate Etavopivat for the Treatment of Anemia in Patients with Myelodysplastic Syndromes (MDS).
You can participate in this study if you are diagnosed with Myelodysplastic Syndromes (MDS). In this study we will evaluate the study drug (Etavopivat) for ...Phase
Interventional
Accepts Healthy Volunteer
-
A Randomized Double-blind Placebo-Controlled Phase 2 Study to Evaluate the Efficacy Safety Tolerability Pharmacokinetics and Pharmacodynamics of Intravenous TAK-341 in Subjects With Multiple System Atrophy
The main purpose of this study is to assess the effectiveness and safety of TAK-341 in adult subjects with multiple system atrophy. Multiple system atrophy ...Phase
Interventional
Accepts Healthy Volunteer
-
A Phase A Phase 2 Randomized Double-Blind Double-Dummy Placebo-Controlled Study Evaluating the Safety and Efficacy of Semaglutide and the Fixed-Dose Combination of Cilofexor and Firsocostat Alone and in Combination in Subjects with Compensated Cirrhosis (F4) due to Nonalcoholic Steatohepatitis (NASH)
The purpose of this study is to see if the investigational drugs semaglutide, the fixed-dose combination of CILO/FIR, and their combination are safe and ...Phase
Interventional
Accepts Healthy Volunteer
